Tag: Bempedoic acid

According to the European Medicines Agency (EMA), several effective non-statin medications are approved for patients with high cholesterol. These therapies provide vital alternatives for individuals unable to tolerate statins or who require further low-density lipoprotein cholesterol (LDL-C) reduction. The question of **what does Europe use instead of statins** reveals a landscape of modern pharmaceutical options complementing or replacing traditional statin use.

About 86 million U.S. adults have total cholesterol levels over 200 mg/dL [1.4.2]. For many, medication is essential for management, which raises a critical question: which cholesterol drug is safest?

Approximately 15 percent of people experience side effects, such as muscle aches, from statin medications, leading to discontinuation of treatment. This has fueled the development of newer alternatives, such as the **new cholesterol drug that is not a statin**, offering new hope for effective lipid management.